Former Twitter and Google executives Elad Gil and Othman Laraki have decided to support a Burlingame startup pushing, a genetic sequencing test for breast and ovarian cancers for $249.

According to Color Genomics, its Color Test is going to analyze 19 genes connected to an inherited predisposition to breast and ovarian cancer, involving the BRCA1 and BRCA2 genes.

Angelina Jolie has tested for BRCA1, and had a preventative double mastectomy. Most recently, she had her ovaries and fallopian tubes removed. Most famously actor-director Angelina Jolie helped to bring attention to the importance of getting genetic testing for cancer risk. According to critics, genetic tests can be complex to interpret and can also lead to unnecessary surgeries.

"We founded Color because we want to give every person the opportunity to understand their genetic risk of cancer. This important information gives people the opportunity to work with their physician to manage their risk and make key life choices", said Gil, Color's CEO.

The majority of Color's hopes are reliant on the price of its Color Test for instance, rival Myriad Genetics charges about $4,000 before insurance. Laraki, Color's president, said they have developed something that various did not think was feasible, a high-quality yet reasonable genetic test for BRCA1, BRCA2 and 17 other key genes.

Investors who pumped $15 million into Color are as follows: Khosla Ventures, Google board member Ann Mather, BlackRock cofounder and director Sue Wagner. Color is working with UCSF and the University of Washington to give free testing to women who can't pay for testing. Color Genomics wants to democratize access to this genetic information that can finally save lives.